An Open-label, Multicenter, Single-group Study to Evaluate the Effects of Long-term Use of Mucinex® in Patients With Stable Chronic Bronchitis.
This is an open-label, multicenter, single-group study designed to determine the effectiveness of Mucinex® when used by patients to treat SCB over a 12-week period, following a 2-week run-in period of no treatment (to establish a baseline).
100 Clinical Results associated with American Health Research, LLC
0 Patents (Medical) associated with American Health Research, LLC
100 Deals associated with American Health Research, LLC
100 Translational Medicine associated with American Health Research, LLC